Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG Oligonucleotide

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Smolianov, Vsevolod ^a   Dehmel, Thomas ^a   Vollmar, Patrick ^b   Mausberg, Anne K ^a   Kieseier, Bernd C ^a   Hemmer, Bernhard ^b   Hartung, Hans P ^a   Hofstetter, Harald H ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGONUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 17; OLIGONUCLEOTIDE; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 139 151; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; AUTOANTIBODY; CPG-OLIGONUCLEOTIDE; CYTOKINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; MYELIN PROTEOLIPID PROTEIN (139 151); MYELIN PROTEOLIPID PROTEIN (139-151); OLIGODEOXYRIBONUCLEOTIDE; PEPTIDE FRAGMENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNOSTIMULATION; INFECTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; SPLEEN CELL; SWISS JAMES LAMBERT MOUSE; T LYMPHOCYTE; ADOPTIVE TRANSFER; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; IMMUNOLOGY;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2; MICE; MYELIN PROTEOLIPID PROTEIN; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 79957566162     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-59     Document Type: Article

References (28)

1. Chervonsky AV. Influence of microbial environment on autoimmunity. Nature Immunology 2010, 11:28-35. 10.1038/ni.1801, 20016507.
2. Christen U, von Herrath MG. Infections and autoimmunity - good or bad?. J Immunol 2005, 174:7481-6.
3. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010, 67:824-30. 3089959, 20517945.
4. Casiraghi C, Dorovini-Zis K, Horwitz MS. Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J Neuroimmunol 2011, 230:173-7. 10.1016/j.jneuroim.2010.08.003, 20826008.
5. Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009, 183:6041-50. 10.4049/jimmunol.0900747, 19841183.
6. Andersen O, Lygner PE, Bergström T, Andersson M, Vahlne A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993, 240:417-22. 10.1007/BF00867354, 8410082.
7. Buljevac D, Flach HZ, Hop WCJ, et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002, 125:952-60. 10.1093/brain/awf098, 11960885.
8. Correale J, Farez M. Monocyte-derived dendritic cells in multiple sclerosis: the effect of bacterial infection. J Neuroimmunol 2007, 190:177-89. 10.1016/j.jneuroim.2007.08.011, 17936916.
9. Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998, 64:736-41. 10.1136/jnnp.64.6.736, 2170117, 9647301.
10. Nogai A, Siffrin V, Bonhagen K, et al. Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells. J Immunol 2005, 175:959-66.
11. Prinz M, Garbe F, Schmidt H, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of EAE. J Clin Invest 2006, 116:456-64. 10.1172/JCI26078, 1350999, 16440059.
12. Serres S, Anthony DC, Jiang Y, et al. Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J Neuroscience 2009, 29:4820-8.
13. Korn T, Oukka M, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007, 19:362-71. 10.1016/j.smim.2007.10.007, 2839934, 18035554.
14. Hofstetter HH, Ibrahim SM, Koczan D, et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 2005, 237:123-30. 10.1016/j.cellimm.2005.11.002, 16386239.
15. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM. IL-12 and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile and response to cytokine inhibition. J Exp Med 2008, 205:1535-41. 10.1084/jem.20080159, 2442630, 18573909.
16. Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810. 10.1084/jem.20071258, 2292220, 18391061.
17. Ichikawa TH, Williams LP, Segal BM. Activation of APCs through CD40 or Toll-like Receptor 9 overcomes tolerance and precipitates autoimmune disease. J Immunol 2002, 169:2781-7.
18. Bendigs S, Salzer U, Lipford GB, Wagner H, Heeg K. CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells. Eur J Immunol 1999, 29:1209-18. 10.1002/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J, 10229088.
19. Hofstetter HH, Shive CL, Forsthuber TG. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J Immunol 2002, 169:117-25.
20. Hofstetter HH, Toyka KV, Tary-Lehmann M, Lehmann PV. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J Immunol 2007, 178:1372-8.
21. Segal BM, Dwyer BK, Shevach EM. CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J Immunol 2000, 164:5683-90.
22. Tigno-Aranjuez JT, Jaini R, Tuohy VK, Lehmann PV, Tary-Lehmann M. Encephalitogenicity of CFA relative to CpG is linked to induction of Th17 cells. J Immunol 2009, 183:5654-61. 10.4049/jimmunol.0900645, 19812193.
23. Hansen BS, Hussain RZ, Lovett-Racke AE, Thomas JA, Racke MK. Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity. J Neuroimmunol 2006, 172:94-103. 10.1016/j.jneuroim.2005.11.006, 16360885.
24. Marta M, Andersson A, Isaksson M, Kämpe O, Lobell A. Unexpected regulatory roles of TLR4 and TLR9 in EAE. Eur J Immunol 2008, 38:565-75. 10.1002/eji.200737187, 18203139.
25. Hermann I, Kellert M, Schmidt H, et al. Streptococcus pneumoniae infection aggravates EAE via toll-like receptor 2. Infection and Immunity 2006, 74:4841-8. 10.1128/IAI.00026-06, 1539614, 16861672.
26. Tsunoda I, Tolley ND, Theil DJ, Whitton JL, Kobayashi H, Fujinami RS. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathology 1999, 9:481-93.
27. Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 2008, 14:337-42. 10.1038/nm1715, 2813727, 18278054.
28. Haak S, Croxford AL, Kreymborg K, et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 2008, 119:61-9. 2613466, 19075395.